Back
Radiation associated coronary occlusion: Overlooked as trastuzumab-induced cardiomyopathy
Ugur Turk, Veysel Yavuz, Nurullah Cetin
Open J. Intern. Med. Vol.3 No.1, March 22, 2013  DOI: 10.4236/ojim.2013.31001
       (PDF  177K)     HTML      XML
Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study
Srinivasa Belagutty Jayappa, Bhanu Prakash Lalkota, Veluswamy Mani, Reshma Elsa Jenny, Kiran P. Krishnamurthi, Vinu Sarathy, S. Thineshwaran, Bayas Nithin, Sumithra Martinovic, Amritanshu Ram, Shekar Patil, Radheshyam Naik
Adv. Breast Cancer Res. Vol.9 No.4, September 15, 2020  DOI: 10.4236/abcr.2020.94009
       (PDF  319K)     HTML      XML
Trastuzumab Re-Introduction with FOLFIRI for Treatment of HER2 Overexpression-Advanced Gastric Adenocarcinoma Following Failure of Other Trastuzumab-Based Chemotherapy Regimens
Olivier Dubreuil, Aziz Zaanan, Olivier Pellerin, Jean-Baptiste Bachet, Philippe Rougier, Julien Taieb
Case Rep. Clin. Med. Vol.4 No.4, April 17, 2015  DOI: 10.4236/crcm.2015.44028
       (PDF  526K)     HTML      XML
A Single Centre Experience with Phenotype Dependent Perioperative Chemotherapy for Primary Breast Cancer
Tamás Kullmann, Kofi Agyemang-Prempeh, Adél Ambrus, Gabriella Herodek, Balázs Hillier, Károly Kocsis, Ilona Laszip, Mária Mák, Tamás Pintér, István Sipőcz
J. Cancer Ther. Vol.10 No.1, January 04, 2019  DOI: 10.4236/jct.2019.101002
       (PDF  339K)     HTML      XML
Evaluating the evolving evidence: The challenges of molecular-targeted therapy in management of gastric cancer
Yasar Albushra Abdul Rahiem Ahmed, Mohamed Ali
Open J. Gastroenterol. Vol.4 No.1, January 10, 2014  DOI: 10.4236/ojgas.2014.41002
       (PDF  193K)     HTML     
 
 
Top